Dramatic phase 2 duration randomized MDR-TB treatment trial

Ended Cooperative Agreement Awarded Last action

Award ID
U01AI152980
Recipient
Awarding agency
Obligated
$18,074,824

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $15,375,177.39 Federal
  • $2,699,647.00 Non-federal
Place of performance
San Francisco, CA 94158, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $14,528 $0
Amendment -$34,512 $0
Amendment -$14,528 $0
Amendment Dramatic phase 2 duration randomized MDR-TB treatment trial - dramatic project summary / abstract multidrug-resistant tuberculosis (MDR-TB) was estimated to… $0 $0
Amendment Dramatic phase 2 duration randomized MDR-TB treatment trial - multidrug-resistant tuberculosis (MDR-TB) was estimated to occur 600,000 people in 2017. The… $44,991 $0
Amendment Dramatic phase 2 duration randomized MDR-TB treatment trial - dramatic project summary / abstract multidrug-resistant tuberculosis (MDR-TB) was estimated to… $44,991 $0
Amendment $481,962 $0
Amendment Dramatic phase 2 duration randomized MDR-TB treatment trial - multidrug-resistant tuberculosis (MDR-TB) was estimated to occur 600,000 people in 2017. The… $481,962 $0
Amendment $481,962 $0
Amendment $184,085 $0
Amendment $92,645 $0
Amendment $184,085 $0
Amendment $92,645 $0
Amendment $92,645 $0
Amendment $184,085 $0
Amendment $1,157,460 $0
Amendment $1,157,460 $0
Amendment $1,157,460 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,350,629 $0
Amendment $1,350,629 $0
Amendment $1,342,487 $0
Amendment $1,342,487 $1,342,487
Amendment $1,357,160 $0
Amendment Dramatic phase 2 duration randomized MDR-TB treatment trial - dramatic project summary / abstract multidrug-resistant tuberculosis (MDR-TB) was estimated to… $1,357,160 $1,357,160
Original award $1,470,699 $0
Show all 28

Subawards

Subrecipient Amount Awarded
Trustees Of Boston University DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial $60,328
TB HIV Innovations And Clinical Research Foundation Corp. TB-HIV Innovations and Clinical Research (THINCR) _DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial $184,085
Vietnam National Lung Hospital Vietnam National Lung Hospital_DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial $92,945
The Regents Of The University Of Colorado Title: Prospective, Duration-Randomized, Partially Blinded, Phase 2 Study of the Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid,… $186,611
President And Fellows Of Harvard College Title: Prospective, Duration-Randomized, Partially Blinded, Phase 2 Study of the Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid,… $119,062
Westat, Inc. Project Description (including objectives, tasks, and deliverables as applicable): x Ms. Dianis will advise the Co-PIs on design and construction of the data… $750,637
Hermano (San) Miguel Febres Cordero Medical Education Foundation (DE La Salle Medical And Health Sciences Institute) Inc. Project Description (including objectives, tasks, and deliverables as applicable): The DLSHSI site will be responsible for: • Providing oversight and… $1,012,058
Vietnam National Lung Hospital Project Description (including objectives, tasks, and deliverables as applicable): The Vietnam National Lung Hospital site will be responsible for: x… $798,648
Center For Promotion Of Advancement Of Society Project Description (including objectives, tasks, and deliverables as applicable): CPAS Vietnam will be responsible for: x Providing oversight to the study… $254,484
Trustees Of Boston University Scope of Work Start/End Dates: x Obtaining IP from the manufacturers (and the National TB Program, where indicated), overseeing shipping to the sites,… $2,373,799

Quick answers

Who received award U01AI152980?

U01AI152980 was awarded to The Regents Of The University Of California. San Francisco by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 21, 2020.

How much is award U01AI152980 worth?

$18,074,824 has been obligated on U01AI152980: $15,375,177 in federal funding and $2,699,647 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login